HYPRMICRO

Hyperfine, Inc.

HealthcareMedical - Devices
$1.68
$0.00(-2.89%)
52W$0.53
$2.22
Updated May 8, 12:00 AM
RSI72
RS Rating92/99
Beta2.63
Volatility107%
F-Score3/9
Mkt Cap$158M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Hyperfine, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 92), indicating clear outperformance against the broad market. Earnings growth of 57% provides fundamental context to the price action. However, price is extended 34% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
92
out of 99
Market Leader
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
2.63
vs S&P 500
HIGH BETA
52W Position
68%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.26
50 SMA > 100 SMA$1.18
100 SMA > 150 SMA$1.20
150 SMA > 200 SMA$1.22

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.43+17.61%ABOVE
50 SMA$1.26+33.72%ABOVE
100 SMA$1.18+42.72%ABOVE
150 SMA$1.20+39.73%ABOVE
200 SMA$1.22+37.68%ABOVE

Price Performance

1D-2.9%
1W+1.2%
1M+51.4%
3M+47.4%
6M+57.0%
YTD+73.4%
1Y+137.1%
3Y+4.8%
52-Week Trading Range68% from low
$1.68
52W Low$0.53
52W High$2.22

Technical Indicators

RSI (14)OVERBOUGHT
71.7
305070
VCP ScoreCOOL
1/10
Base depth: 55.1%

Risk Profile

Beta
2.63
52W Vol
107%
ATR
$0.11
Max DD (1Y)
-59%

Volume Analysis

Today
457.7K
50D Avg
608.2K
Vol Ratio
0.75x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25+14%
$-0.12
Q2'25+14%
$-0.12
Q3'25
$-0.14
Q4'25+57%
$-0.06
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+115.18%
3 Years:+25.79%
TTM:+5.22%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+21.29%

Stock Price CAGR

10 Years:-16.35%
5 Years:-29.94%
3 Years:+4.79%
1 Year:+137.09%

Return on Equity

10Y Avg:-56.4%
5Y Avg:-56.2%
3Y Avg:-60.9%
Last Year:-97.4%

Key Metrics

Market Cap$158M
Gross Margin49.8%
Net Margin-2.6%
Piotroski F-Score3/9

Frequently Asked Questions

Is HYPR in an uptrend right now?

HYPR has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is HYPR overbought or oversold?

HYPR's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is HYPR outperforming the market?

HYPR has a Relative Strength (RS) Rating of 92 out of 99. Yes, HYPR is a market leader, outperforming 92% of all stocks over the past 12 months.

Where is HYPR in its 52-week range?

HYPR is trading at $1.68, which is 76% of its 52-week high ($2.22) and 68% above its 52-week low ($0.53).

How volatile is HYPR?

HYPR has a Beta of 2.63 and 52-week volatility of 107%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.